The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Gene Therapy For Cancer Market Research Report 2025
Synopsis
Gene therapy refers to the introduction of foreign genes into target cells to correct or compensate for diseases caused by gene defects and/or abnormal gene expression.
The global Gene Therapy For Cancer market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Gene Therapy For Cancer is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Gene Therapy For Cancer is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Gene Therapy For Cancer in Cancer Treatment is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Gene Therapy For Cancer include GLIEAD, REGENXBIO, Autolus, American Gene Technologies, Arcellx, AUSTRIANOVA, Alphavax, Cellectis and Chimeron, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Gene Therapy For Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapy For Cancer.
Report Scope
The Gene Therapy For Cancer market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gene Therapy For Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Therapy For Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GLIEAD
REGENXBIO
Autolus
American Gene Technologies
Arcellx
AUSTRIANOVA
Alphavax
Cellectis
Chimeron
Segment by Type
Rb Gene
P53 Gene
APC Gene
NF1 Gene
Others
Segment by Application
Cancer Treatment
Tissue Repair
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Therapy For Cancer companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Gene therapy refers to the introduction of foreign genes into target cells to correct or compensate for diseases caused by gene defects and/or abnormal gene expression.
The global Gene Therapy For Cancer market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Gene Therapy For Cancer is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Gene Therapy For Cancer is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Gene Therapy For Cancer in Cancer Treatment is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Gene Therapy For Cancer include GLIEAD, REGENXBIO, Autolus, American Gene Technologies, Arcellx, AUSTRIANOVA, Alphavax, Cellectis and Chimeron, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Gene Therapy For Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapy For Cancer.
Report Scope
The Gene Therapy For Cancer market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gene Therapy For Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Therapy For Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GLIEAD
REGENXBIO
Autolus
American Gene Technologies
Arcellx
AUSTRIANOVA
Alphavax
Cellectis
Chimeron
Segment by Type
Rb Gene
P53 Gene
APC Gene
NF1 Gene
Others
Segment by Application
Cancer Treatment
Tissue Repair
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Therapy For Cancer companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy For Cancer Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Rb Gene
1.2.3 P53 Gene
1.2.4 APC Gene
1.2.5 NF1 Gene
1.2.6 Others
1.3 Market by Application
1.3.1 Global Gene Therapy For Cancer Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cancer Treatment
1.3.3 Tissue Repair
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapy For Cancer Market Perspective (2019-2030)
2.2 Gene Therapy For Cancer Growth Trends by Region
2.2.1 Global Gene Therapy For Cancer Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Gene Therapy For Cancer Historic Market Size by Region (2019-2024)
2.2.3 Gene Therapy For Cancer Forecasted Market Size by Region (2025-2030)
2.3 Gene Therapy For Cancer Market Dynamics
2.3.1 Gene Therapy For Cancer Industry Trends
2.3.2 Gene Therapy For Cancer Market Drivers
2.3.3 Gene Therapy For Cancer Market Challenges
2.3.4 Gene Therapy For Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Therapy For Cancer Players by Revenue
3.1.1 Global Top Gene Therapy For Cancer Players by Revenue (2019-2024)
3.1.2 Global Gene Therapy For Cancer Revenue Market Share by Players (2019-2024)
3.2 Global Gene Therapy For Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gene Therapy For Cancer Revenue
3.4 Global Gene Therapy For Cancer Market Concentration Ratio
3.4.1 Global Gene Therapy For Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy For Cancer Revenue in 2023
3.5 Gene Therapy For Cancer Key Players Head office and Area Served
3.6 Key Players Gene Therapy For Cancer Product Solution and Service
3.7 Date of Enter into Gene Therapy For Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapy For Cancer Breakdown Data by Type
4.1 Global Gene Therapy For Cancer Historic Market Size by Type (2019-2024)
4.2 Global Gene Therapy For Cancer Forecasted Market Size by Type (2025-2030)
5 Gene Therapy For Cancer Breakdown Data by Application
5.1 Global Gene Therapy For Cancer Historic Market Size by Application (2019-2024)
5.2 Global Gene Therapy For Cancer Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Gene Therapy For Cancer Market Size (2019-2030)
6.2 North America Gene Therapy For Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Gene Therapy For Cancer Market Size by Country (2019-2024)
6.4 North America Gene Therapy For Cancer Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Therapy For Cancer Market Size (2019-2030)
7.2 Europe Gene Therapy For Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Gene Therapy For Cancer Market Size by Country (2019-2024)
7.4 Europe Gene Therapy For Cancer Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Therapy For Cancer Market Size (2019-2030)
8.2 Asia-Pacific Gene Therapy For Cancer Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Gene Therapy For Cancer Market Size by Region (2019-2024)
8.4 Asia-Pacific Gene Therapy For Cancer Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Therapy For Cancer Market Size (2019-2030)
9.2 Latin America Gene Therapy For Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Gene Therapy For Cancer Market Size by Country (2019-2024)
9.4 Latin America Gene Therapy For Cancer Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Therapy For Cancer Market Size (2019-2030)
10.2 Middle East & Africa Gene Therapy For Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Gene Therapy For Cancer Market Size by Country (2019-2024)
10.4 Middle East & Africa Gene Therapy For Cancer Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GLIEAD
11.1.1 GLIEAD Company Detail
11.1.2 GLIEAD Business Overview
11.1.3 GLIEAD Gene Therapy For Cancer Introduction
11.1.4 GLIEAD Revenue in Gene Therapy For Cancer Business (2019-2024)
11.1.5 GLIEAD Recent Development
11.2 REGENXBIO
11.2.1 REGENXBIO Company Detail
11.2.2 REGENXBIO Business Overview
11.2.3 REGENXBIO Gene Therapy For Cancer Introduction
11.2.4 REGENXBIO Revenue in Gene Therapy For Cancer Business (2019-2024)
11.2.5 REGENXBIO Recent Development
11.3 Autolus
11.3.1 Autolus Company Detail
11.3.2 Autolus Business Overview
11.3.3 Autolus Gene Therapy For Cancer Introduction
11.3.4 Autolus Revenue in Gene Therapy For Cancer Business (2019-2024)
11.3.5 Autolus Recent Development
11.4 American Gene Technologies
11.4.1 American Gene Technologies Company Detail
11.4.2 American Gene Technologies Business Overview
11.4.3 American Gene Technologies Gene Therapy For Cancer Introduction
11.4.4 American Gene Technologies Revenue in Gene Therapy For Cancer Business (2019-2024)
11.4.5 American Gene Technologies Recent Development
11.5 Arcellx
11.5.1 Arcellx Company Detail
11.5.2 Arcellx Business Overview
11.5.3 Arcellx Gene Therapy For Cancer Introduction
11.5.4 Arcellx Revenue in Gene Therapy For Cancer Business (2019-2024)
11.5.5 Arcellx Recent Development
11.6 AUSTRIANOVA
11.6.1 AUSTRIANOVA Company Detail
11.6.2 AUSTRIANOVA Business Overview
11.6.3 AUSTRIANOVA Gene Therapy For Cancer Introduction
11.6.4 AUSTRIANOVA Revenue in Gene Therapy For Cancer Business (2019-2024)
11.6.5 AUSTRIANOVA Recent Development
11.7 Alphavax
11.7.1 Alphavax Company Detail
11.7.2 Alphavax Business Overview
11.7.3 Alphavax Gene Therapy For Cancer Introduction
11.7.4 Alphavax Revenue in Gene Therapy For Cancer Business (2019-2024)
11.7.5 Alphavax Recent Development
11.8 Cellectis
11.8.1 Cellectis Company Detail
11.8.2 Cellectis Business Overview
11.8.3 Cellectis Gene Therapy For Cancer Introduction
11.8.4 Cellectis Revenue in Gene Therapy For Cancer Business (2019-2024)
11.8.5 Cellectis Recent Development
11.9 Chimeron
11.9.1 Chimeron Company Detail
11.9.2 Chimeron Business Overview
11.9.3 Chimeron Gene Therapy For Cancer Introduction
11.9.4 Chimeron Revenue in Gene Therapy For Cancer Business (2019-2024)
11.9.5 Chimeron Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Gene Therapy For Cancer Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Rb Gene
Table 3. Key Players of P53 Gene
Table 4. Key Players of APC Gene
Table 5. Key Players of NF1 Gene
Table 6. Key Players of Others
Table 7. Global Gene Therapy For Cancer Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Gene Therapy For Cancer Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Gene Therapy For Cancer Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Gene Therapy For Cancer Market Share by Region (2019-2024)
Table 11. Global Gene Therapy For Cancer Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Gene Therapy For Cancer Market Share by Region (2025-2030)
Table 13. Gene Therapy For Cancer Market Trends
Table 14. Gene Therapy For Cancer Market Drivers
Table 15. Gene Therapy For Cancer Market Challenges
Table 16. Gene Therapy For Cancer Market Restraints
Table 17. Global Gene Therapy For Cancer Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Gene Therapy For Cancer Market Share by Players (2019-2024)
Table 19. Global Top Gene Therapy For Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy For Cancer as of 2023)
Table 20. Ranking of Global Top Gene Therapy For Cancer Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Gene Therapy For Cancer Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Gene Therapy For Cancer Product Solution and Service
Table 24. Date of Enter into Gene Therapy For Cancer Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Gene Therapy For Cancer Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Gene Therapy For Cancer Revenue Market Share by Type (2019-2024)
Table 28. Global Gene Therapy For Cancer Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Gene Therapy For Cancer Revenue Market Share by Type (2025-2030)
Table 30. Global Gene Therapy For Cancer Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Gene Therapy For Cancer Revenue Market Share by Application (2019-2024)
Table 32. Global Gene Therapy For Cancer Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Gene Therapy For Cancer Revenue Market Share by Application (2025-2030)
Table 34. North America Gene Therapy For Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Gene Therapy For Cancer Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Gene Therapy For Cancer Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Gene Therapy For Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Gene Therapy For Cancer Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Gene Therapy For Cancer Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Gene Therapy For Cancer Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Gene Therapy For Cancer Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Gene Therapy For Cancer Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Gene Therapy For Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Gene Therapy For Cancer Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Gene Therapy For Cancer Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Gene Therapy For Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Gene Therapy For Cancer Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Gene Therapy For Cancer Market Size by Country (2025-2030) & (US$ Million)
Table 49. GLIEAD Company Detail
Table 50. GLIEAD Business Overview
Table 51. GLIEAD Gene Therapy For Cancer Product
Table 52. GLIEAD Revenue in Gene Therapy For Cancer Business (2019-2024) & (US$ Million)
Table 53. GLIEAD Recent Development
Table 54. REGENXBIO Company Detail
Table 55. REGENXBIO Business Overview
Table 56. REGENXBIO Gene Therapy For Cancer Product
Table 57. REGENXBIO Revenue in Gene Therapy For Cancer Business (2019-2024) & (US$ Million)
Table 58. REGENXBIO Recent Development
Table 59. Autolus Company Detail
Table 60. Autolus Business Overview
Table 61. Autolus Gene Therapy For Cancer Product
Table 62. Autolus Revenue in Gene Therapy For Cancer Business (2019-2024) & (US$ Million)
Table 63. Autolus Recent Development
Table 64. American Gene Technologies Company Detail
Table 65. American Gene Technologies Business Overview
Table 66. American Gene Technologies Gene Therapy For Cancer Product
Table 67. American Gene Technologies Revenue in Gene Therapy For Cancer Business (2019-2024) & (US$ Million)
Table 68. American Gene Technologies Recent Development
Table 69. Arcellx Company Detail
Table 70. Arcellx Business Overview
Table 71. Arcellx Gene Therapy For Cancer Product
Table 72. Arcellx Revenue in Gene Therapy For Cancer Business (2019-2024) & (US$ Million)
Table 73. Arcellx Recent Development
Table 74. AUSTRIANOVA Company Detail
Table 75. AUSTRIANOVA Business Overview
Table 76. AUSTRIANOVA Gene Therapy For Cancer Product
Table 77. AUSTRIANOVA Revenue in Gene Therapy For Cancer Business (2019-2024) & (US$ Million)
Table 78. AUSTRIANOVA Recent Development
Table 79. Alphavax Company Detail
Table 80. Alphavax Business Overview
Table 81. Alphavax Gene Therapy For Cancer Product
Table 82. Alphavax Revenue in Gene Therapy For Cancer Business (2019-2024) & (US$ Million)
Table 83. Alphavax Recent Development
Table 84. Cellectis Company Detail
Table 85. Cellectis Business Overview
Table 86. Cellectis Gene Therapy For Cancer Product
Table 87. Cellectis Revenue in Gene Therapy For Cancer Business (2019-2024) & (US$ Million)
Table 88. Cellectis Recent Development
Table 89. Chimeron Company Detail
Table 90. Chimeron Business Overview
Table 91. Chimeron Gene Therapy For Cancer Product
Table 92. Chimeron Revenue in Gene Therapy For Cancer Business (2019-2024) & (US$ Million)
Table 93. Chimeron Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene Therapy For Cancer Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Gene Therapy For Cancer Market Share by Type: 2023 VS 2030
Figure 3. Rb Gene Features
Figure 4. P53 Gene Features
Figure 5. APC Gene Features
Figure 6. NF1 Gene Features
Figure 7. Others Features
Figure 8. Global Gene Therapy For Cancer Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Gene Therapy For Cancer Market Share by Application: 2023 VS 2030
Figure 10. Cancer Treatment Case Studies
Figure 11. Tissue Repair Case Studies
Figure 12. Others Case Studies
Figure 13. Gene Therapy For Cancer Report Years Considered
Figure 14. Global Gene Therapy For Cancer Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Gene Therapy For Cancer Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Gene Therapy For Cancer Market Share by Region: 2023 VS 2030
Figure 17. Global Gene Therapy For Cancer Market Share by Players in 2023
Figure 18. Global Top Gene Therapy For Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy For Cancer as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Gene Therapy For Cancer Revenue in 2023
Figure 20. North America Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Gene Therapy For Cancer Market Share by Country (2019-2030)
Figure 22. United States Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Gene Therapy For Cancer Market Share by Country (2019-2030)
Figure 26. Germany Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Gene Therapy For Cancer Market Share by Region (2019-2030)
Figure 34. China Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Gene Therapy For Cancer Market Share by Country (2019-2030)
Figure 42. Mexico Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Gene Therapy For Cancer Market Share by Country (2019-2030)
Figure 46. Turkey Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Gene Therapy For Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. GLIEAD Revenue Growth Rate in Gene Therapy For Cancer Business (2019-2024)
Figure 49. REGENXBIO Revenue Growth Rate in Gene Therapy For Cancer Business (2019-2024)
Figure 50. Autolus Revenue Growth Rate in Gene Therapy For Cancer Business (2019-2024)
Figure 51. American Gene Technologies Revenue Growth Rate in Gene Therapy For Cancer Business (2019-2024)
Figure 52. Arcellx Revenue Growth Rate in Gene Therapy For Cancer Business (2019-2024)
Figure 53. AUSTRIANOVA Revenue Growth Rate in Gene Therapy For Cancer Business (2019-2024)
Figure 54. Alphavax Revenue Growth Rate in Gene Therapy For Cancer Business (2019-2024)
Figure 55. Cellectis Revenue Growth Rate in Gene Therapy For Cancer Business (2019-2024)
Figure 56. Chimeron Revenue Growth Rate in Gene Therapy For Cancer Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
